EUVIMEDEUVIMED entdecken
Crossref

Formulation and Evaluation of Temozolomide Oral Suspension for Brain Tumor Therapy

Prof. Priya Jaware Prof. Priya Jaware, Prof. Amol Wadhave Prof. Amol Wadhave, Dr. Santosh Payghan Dr. Santosh Payghan, Ravindra Narwade Ravindra Narwade

International Journal of Creative and Open Research in Engineering and Management · 22.06.2026 · 02 (06) · 1-8

DOI: 10.55041/ijcope.v2i6.280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 22.06.2026. Verfasst von Prof. Priya Jaware Prof. Priya Jaware und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temozolomide (TMZ) is an alkylating agent widely used in the treatment of glioblastoma multiform and other malignant brain tumors. However, the commercially available capsule dosage form presents challenges in pediatric, geriatric, and dysphagia patients due to swallowing difficulty and dose inflexibility. The present study aims to develop and evaluate a stable, patient-friendly oral suspension of temozolomide using a Quality-based pharmaceutics approach. A novel citrate-buffered, polymer-stabilized suspension was formulated to enhance chemical stability and dosing accuracy. Keywords: Temozolomide, Oral suspension, Brain tumor, Glioblastoma, Pediatric formulation, Stability study.

Zitieren

APA

Jaware, P. P. J. P. P., Wadhave, P. A. W. P. A., Payghan, D. S. P. D. S., & Narwade, R. N. R. (2026). Formulation and Evaluation of Temozolomide Oral Suspension for Brain Tumor Therapy. International Journal of Creative and Open Research in Engineering and Management, 02(06), 1-8. https://doi.org/10.55041/ijcope.v2i6.280

Vancouver

Jaware PPJPP, Wadhave PAWPA, Payghan DSPDS, Narwade RNR. Formulation and Evaluation of Temozolomide Oral Suspension for Brain Tumor Therapy. International Journal of Creative and Open Research in Engineering and Management. 2026;02(06):1-8. doi:10.55041/ijcope.v2i6.280

BibTeX
@article{Jaware2026,
  author = {Jaware, Prof. Priya Jaware Prof. Priya and Wadhave, Prof. Amol Wadhave Prof. Amol and Payghan, Dr. Santosh Payghan Dr. Santosh and Narwade, Ravindra Narwade Ravindra},
  title = {Formulation and Evaluation of Temozolomide Oral Suspension for Brain Tumor Therapy},
  journal = {International Journal of Creative and Open Research in Engineering and Management},
  year = {2026},
  volume = {02},
  number = {06},
  pages = {1--8},
  doi = {10.55041/ijcope.v2i6.280}
}
Kostenlos starten →